Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy for trans individuals is effective and generally safe in the short term.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Androgens, like testosterone, are crucial for early testicular descent in rats.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Ganoderma lucidum, a type of mushroom, may help treat enlarged prostate by blocking testosterone conversion.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Finasteride effectively treats male hair loss, improving growth and density.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

AR gene not major factor in female hair loss; different from male hair loss.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Berberine may reduce prostate enlargement by blocking inflammation.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.